Viridian Therapeutics, Inc. · NASDAQ:VRDN

Deep Track Capital, LP reported a 5.30% stake in Viridian Therapeutics, Inc. (Schedule 13G)

Event May 1, 2026 · Filed May 8, 2026

Deep Track Capital, LP reported a 5.30% stake in Viridian Therapeutics, Inc., 5,417,660 shares, as a passive investor on May 1, 2026. Filed May 8, 2026 (Schedule 13G).

Stake
5.30%
Shares
5,417,660
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP5.30%5,417,660
Deep Track Biotechnology Master Fund, Ltd.5.30%5,417,660
David Kroin5.30%5,417,660

Source

View original at SEC

Related